Kyntra Bio, Inc.
Kyntra Bio, Inc. (KYNB) Stock Overview
Explore Kyntra Bio, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
28.4M
P/E Ratio
0.15
EPS (TTM)
$-14.40
ROE
-1.62%
KYNB Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Kyntra Bio, Inc. (KYNB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 48.56, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $44.94.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.15 and a market capitalization of 28.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.